Palisade Bio Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Mar 2026
Net Income -$16.8MTTM through 31 Mar 2026
Free Cash Flow -$12.4MTTM through 31 Mar 2026
Margins
| Current |
|---|
Returns
-7.5%ROE
-7.2%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio23.71x
Net Debt-$132.6Mnet cash position
Cash & Equivalents$132.6M
Quality Metrics
Earnings-Beat Rate0.0%
Dividend
No dividend
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.